Announcements

Robert W. McMahon, SVP and Chief Financial Officer of West Pharmaceutical Services Inc, filed a Form 4 on August 12, 2026, disclosing restricted stock unit vesting and related share withholding transactions dated August 11, 2026.

Andre Spolidoro Ferreira Gomes, Chief Strategy Officer of VTEX, filed a Form 4 on August 12, 2026, disclosing the sale of 15,000 Class A Common Shares on August 10, 2026.

Kimberly A. Kuryea, Senior Vice President and CFO of General Dynamics Corp, filed a Form 4 on August 12, 2026, reporting transactions in the company's common stock dated August 10, 2026.

Director Joshua Bershad filed a Form 4 with the SEC on August 12, 2026, disclosing a disposition of 6,900 shares of Middlesex Water Co common stock on August 11, 2026, via a trust distribution at a price of $0.

A Form 4 filed on August 12, 2026, reported that Peter A. Wall, a director of General Dynamics Corp, exercised stock options and sold shares of common stock on August 10, 2026.

Robert J. More, a director of Vir Biotechnology, Inc. (NASDAQ:VIR), filed a Form 4 on August 12, 2026, reporting a transaction dated August 11, 2026, in which 8,000 shares of common stock were transferred to Alta Partners NextGen Fund I, L.P. at no consideration …

Robert H. Friend, Executive Vice President and Chief Credit Officer of WesBanco Inc (NASDAQ:WSBC), filed a Form 4 on August 12, 2026, reporting four transactions in common stock on August 11, 2026, involving the exercise of two stock option grants and the same-day sale …